reviewNew England Journal of MedicineNov 24, 2017GREEN OA

Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy

RZRobert ZeiserBRBruce R. Blazar

University Medical Center Freiburg

PubMed
Indexed incrossrefpubmed

Abstract

When T cells from a bone marrow donor begin to attack the host within 3 months after hematopoietic-cell transplantation, acute graft-versus-host disease results. The disease mainly affects the skin, liver, and gastrointestinal tract and is treated with immunosuppressive drugs.

Citation impact

1,274
total citations
FWCI
54.57
Percentile
100%
References
127
Citations per year

Authors

2

Topics & keywords

Topics
Keywords
  • Medicine
  • Graft-versus-host disease
  • Intensive care medicine
  • Disease
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.